Buprenorphine Transdermal System
Sponsors
Mundipharma K.K., Purdue Pharma LP, Mundipharma (China) Pharmaceutical Co. Ltd, Jenna-Leigh Wilson
Conditions
Ankle Fracture SurgeryDisease (or Disorder); Intervertebral Disc, With Myelopathy (Manifestation)Low Back PainOpioid AnalgesiaOpioid DependenceOpioid Use DisorderOsteoarthritisPain
Phase 3
Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Low Back Pain
CompletedNCT00346047
Start: 2006-05-31End: 2007-07-31Updated: 2008-04-15
Comparison of BTDS (Buprenorphine Transdermal System) and Placebo in Osteoarthritic Pain
CompletedNCT00345787
Start: 2006-05-31End: 2007-08-31Updated: 2008-04-15
Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain
CompletedNCT00490919
Start: 2007-06-30End: 2008-10-31Updated: 2012-09-10
Safety, Pharmacokinetics (PK), and Efficacy of Buprenorphine Transdermal System (BTDS) in Children
CompletedNCT01324570
Start: 2011-07-31End: 2016-05-31Updated: 2017-07-06
NORSPAN Transdermal Patches Phase III Study In Non-Cancer Pain
CompletedNCT01476774
Start: 2009-08-31Updated: 2015-07-08